These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 39282497)

  • 1. Small molecule inhibitors of fungal Δ(9) fatty acid desaturase as antifungal agents against
    Tebbji F; Menon ACT; Khemiri I; St-Cyr DJ; Villeneuve L; Vincent AT; Sellam A
    Front Cell Infect Microbiol; 2024; 14():1434939. PubMed ID: 39282497
    [No Abstract]   [Full Text] [Related]  

  • 2. Alkaloids solenopsins from fire ants display
    Honorato L; Artunduaga Bonilla JJ; Ribeiro da Silva L; Kornetz J; Zamith-Miranda D; Valdez AF; Nosanchuk JD; Gonçalves Paterson Fox E; Nimrichter L
    Virulence; 2024 Dec; 15(1):2413329. PubMed ID: 39370781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
    Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppressing the virulence factors of Candida auris with baicalein through multifaceted mechanisms.
    Li C; Wang J; Li H; Wang Y; Wu H; Wei W; Wu D; Shao J; Wang T; Wang C
    Arch Microbiol; 2024 Jul; 206(8):349. PubMed ID: 38992278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of
    Vélez N; Argel A; Kissmann AK; Alpízar-Pedraza D; Escandón P; Rosenau F; Ständker L; Firacative C
    Front Cell Infect Microbiol; 2024; 14():1389020. PubMed ID: 38601736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Differential Pathogenicity of Candida auris in a Galleria mellonella Infection Model.
    Garcia-Bustos V; Ruiz-Saurí A; Ruiz-Gaitán A; Sigona-Giangreco IA; Cabañero-Navalon MD; Sabalza-Baztán O; Salavert-Lletí M; Tormo MÁ; Pemán J
    Microbiol Spectr; 2021 Sep; 9(1):e0001321. PubMed ID: 34106570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of the global health priority BoxⓇ reveals potential new disinfectants against the emerging multidrug-resistant pathogen Candida auris.
    Retore YI; Lucini F; Pimentel LR; de Oliveira HC; Simionatto S; Rossato L
    Microb Pathog; 2024 Sep; 194():106828. PubMed ID: 39079575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal activity of β-lapachone against a fluconazole-resistant Candida auris strain.
    de Moraes DC; Rollin-Pinheiro R; Pinto MDCFR; Domingos LTS; Barreto-Bergter E; Ferreira-Pereira A
    Braz J Microbiol; 2024 Sep; 55(3):2593-2601. PubMed ID: 38743245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional Profiling of the Candida auris Response to Exogenous Farnesol Exposure.
    Jakab Á; Balla N; Ragyák Á; Nagy F; Kovács F; Sajtos Z; Tóth Z; Borman AM; Pócsi I; Baranyai E; Majoros L; Kovács R
    mSphere; 2021 Oct; 6(5):e0071021. PubMed ID: 34643421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation Inhibition by Rocaglates Activates a Species-Specific Cell Death Program in the Emerging Fungal Pathogen Candida auris.
    Iyer KR; Whitesell L; Porco JA; Henkel T; Brown LE; Robbins N; Cowen LE
    mBio; 2020 Mar; 11(2):. PubMed ID: 32156828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical genetic profiling and characterization of small-molecule compounds that affect the biosynthesis of unsaturated fatty acids in Candida albicans.
    Xu D; Sillaots S; Davison J; Hu W; Jiang B; Kauffman S; Martel N; Ocampo P; Oh C; Trosok S; Veillette K; Wang H; Yang M; Zhang L; Becker J; Martin CE; Roemer T
    J Biol Chem; 2009 Jul; 284(29):19754-64. PubMed ID: 19487691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris.
    Barreto TL; Rossato L; de Freitas ALD; Meis JF; Lopes LB; Colombo AL; Ishida K
    Int J Antimicrob Agents; 2020 Aug; 56(2):106049. PubMed ID: 32544569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
    Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
    mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
    [No Abstract]   [Full Text] [Related]  

  • 14. Verapamil inhibits efflux pumps in
    Vega-Chacón Y; de Albuquerque MC; Pavarina AC; Goldman GH; Mima EGO
    Virulence; 2021 Dec; 12(1):231-243. PubMed ID: 33410730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenylyl Cyclase and Protein Kinase A Play Redundant and Distinct Roles in Growth, Differentiation, Antifungal Drug Resistance, and Pathogenicity of
    Kim JS; Lee KT; Lee MH; Cheong E; Bahn YS
    mBio; 2021 Oct; 12(5):e0272921. PubMed ID: 34663094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of Ginkgolide B combined with fluconazole against drug-resistant Candida albicans based on common resistance mechanisms.
    Li Y; Yang J; Li X; Su S; Chen X; Sun S; Li Y
    Int J Antimicrob Agents; 2020 Aug; 56(2):106030. PubMed ID: 32454072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.
    Sherry L; Ramage G; Kean R; Borman A; Johnson EM; Richardson MD; Rautemaa-Richardson R
    Emerg Infect Dis; 2017 Feb; 23(2):328-331. PubMed ID: 28098553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antifungal 4-chloro-3-nitrophenyldifluoroiodomethyl sulfone reduces the Candida albicans pathogenicity in the Galleria mellonella model organism.
    Staniszewska M; Gizińska M; Kazek M; de Jesús González-Hernández R; Ochal Z; Mora-Montes HM
    Braz J Microbiol; 2020 Mar; 51(1):5-14. PubMed ID: 31486049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence.
    Zhang M; Yan H; Lu M; Wang D; Sun S
    Int J Antimicrob Agents; 2020 Jan; 55(1):105804. PubMed ID: 31605727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galleria mellonella as an alternative in vivo model to study implant-associated fungal infections.
    Mannala GK; Rupp M; Walter N; Scholz KJ; Simon M; Riool M; Alt V
    J Orthop Res; 2023 Nov; 41(11):2547-2559. PubMed ID: 37080929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.